REBUILD: Exercise Tolerance & Pulmonary Fibrosis Study Trial Objective Researchers want to know if inhaled nitric oxide delivered to the lungs will improve exercise tolerance and overall wellbeing of people with pulmonary fibrosis. Participants in the REBUILD study will use an investigational device called INOpulse to inhale nitric oxide every day. They also will wear a wrist monitor to track activity. If needed, transportation to study appointments may be provided. Enrollment Active Clinical Trials Closed to Recruitment Who Can Participate Patients with pulmonary fibrosis who are receiving oxygen therapy. Age: 18-80 Gender: Any Gender Estimated Time Commitment 5 visits over 16 weeks × Payments are intended to compensate the participant for their time and effort during the study. Payments are typically given to the participant at the end of each completed study visit. Reimbursements are intended to compensate the participant for travel-related expenses. They must be approved by the study staff and require you to turn in receipts. Travel reimbursement will vary from study to study. Payment & Reimbursement Payment: Provided Travel Reimbursement: Available Trial Contact For more information, contact: Jennifer Underwood 303-398-1518 Trial Location National Jewish Main Campus, Denver, CO Trial Sponsors Bellerophon Principal Investigators Marjorie Patricia George, MD + × Marjorie Patricia George, MD Associate Professor Director, Pulmonary Hypertension Program Division of Pulmonary, Critical Care & Sleep Medicine Department of Medicine View Full Profile Patient Rating 4.9 out of 5 stars Make an Appoinment Co-Investigators Darlene Kim, MD, FACC + × Darlene Kim, MD, FACC Associate Professor Department of Medicine Division of Cardiology View Full Profile Patient Rating 4.9 out of 5 stars Make an Appoinment Mohammad Dalabih, MD + × Mohammad Dalabih, MD Assistant Professor Division of Pulmonary, Critical Care & Sleep Medicine Department of Medicine View Full Profile Make an Appoinment
Trial Objective Researchers want to know if inhaled nitric oxide delivered to the lungs will improve exercise tolerance and overall wellbeing of people with pulmonary fibrosis. Participants in the REBUILD study will use an investigational device called INOpulse to inhale nitric oxide every day. They also will wear a wrist monitor to track activity. If needed, transportation to study appointments may be provided.